Scientists Must Rise Above Politics — and Restate their Value to Society
By Editorial Board,
Nature
| 08. 07. 2019
Scholars globally are feeling the heat from politicians. They should take inspiration from scientists in the 1950s who raised the alarm over nuclear weapons.
Michael Gove, now a senior minister in the government of UK Prime Minister Boris Johnson, once took a swipe at warnings from academics and other professionals about the risks of Brexit. “People in this country have had enough of experts,” Gove said in 2016, shortly before the United Kingdom voted to leave the European Union.
Three years later, as relations between academics and politicians in a number of democracies are worsening, researchers the world over need to change the perception that they are not to be trusted, or that scientists are somehow separate from the wider population — indeed, polls suggest that trust in scientists in the United States is on the rise.
The need is urgent. At the end of last week, Brazil’s President Jair Bolsonaro sacked the head of the National Institute for Space Research following a stand-off over the agency’s latest reports, which say that deforestation in the Amazon has accelerated during his presidency. In the United States, the Government Accountability Office, a federal watchdog, concluded last month that the Environmental Protection Agency violated ethics rules...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...